March 18, 2018 1:44 PM ET

Life Sciences Tools and Services

Company Overview of STEMCELL Technologies Canada Inc.

Company Overview

STEMCELL Technologies Canada Inc. develops cell culture media, cell separation systems, instruments, and other reagents to support research in the fields of immunology, hematology, neuroscience, mesenchymal stem cell, stem cell, and epithelial cell biology. It offers antibodies, buffers and solutions, cell culture media and supplements, cell dyes and detection assay kits, cell isolation products, cell storage media, cultureware and general supplies, cytokines, density gradient media, ELISAs, instruments and software, laboratory equipment, matrices and substrates, primary and cultured cells, small molecules, standardization tools, and tissue and cell culture dissociation reagents. The company...

570 West Seventh Avenue

Suite 400

Vancouver, BC V5Z 1B3


Founded in 1993





Key Executives for STEMCELL Technologies Canada Inc.

Chief Executive Officer and President
Compensation as of Fiscal Year 2017.

STEMCELL Technologies Canada Inc. Key Developments

STEMCELL Technologies Signs Exclusive License with Propagenix to Commercialize EpiX

STEMCELL Technologies has signed an exclusive license with Propagenix of Rockville, MD to commercialize its patented EpiX™ technology, a novel and revolutionary cell culture medium that enables unprecedented expansion of tissue-resident epithelial stem cells without any genetic manipulation. EpiX™ outperforms current cell culture systems, which typically yield fewer than 20 population doublings before the cells senesce. Epithelial stem cells derived from many tissue types can be propagated more than a trillion-fold in Epix™. The expanded cells are genetically stable, are not tumorigenic, and can be readily differentiated into tissue-specific phenotypes even after extensive expansion.

Oxford Immunotec Ltd. Enters into Second Amendment to Supply Agreement with StemCell Technologies Canada Inc

On September 1, 2017, Oxford Immunotec Ltd. ('OI Ltd.') entered into a second amendment to supply agreement with StemCell Technologies Canada Inc. ('StemCell'). The Second Amendment amends the Supply Agreement between OI Ltd. and StemCell effective January 31, 2008 as amended by an amendment to supply agreement dated October 26, 2011, pursuant to which StemCell supplies OI Ltd. with a product that can be used in performing tests leveraging T-SPOT technology. The second amendment establishes pricing and extends the terms of the agreement until December 31, 2023.

Cellular Dynamics International Signs Distribution Deal with STEMCELL Technologies

Cellular Dynamics International announced that, it has signed a distribution agreement with STEMCELL Technologies. Under the terms of the agreement, STEMCELL Technologies will distribute CDI’s iCell® catalog of products in North America, Europe, and Singapore, with other countries under consideration. CDI’s iCell products are differentiated human induced pluripotent stem cell (iPSC)-derived cells, which include cardiomyocytes, hepatocytes, and others, totaling up to 12 cell types.

Similar Private Companies By Industry

Company Name Region
Acclaim Pharma Research, Inc. Americas
Adapsyn Bioscience Inc. Americas
Allphase Clinical Research Services Inc. Americas
Altasciences Company, Inc. Americas
Altum Pharmaceuticals Inc. Americas

Recent Private Companies Transactions

Private Placement
February 8, 2018

The information and data displayed in this profile are created and managed by S&P Global Market Intelligence, a division of S&P Global. does not create or control the content. For inquiries, please contact S&P Global Market Intelligence directly by clicking here.

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
Lawyers Committee for Civil Rights Under Law United States
The Advertising Council, Inc. United States
Tax Management Inc United States
John F. Kennedy Center For The Performing Arts United States
NYC2012, Inc. United States

Sponsored Financial Commentaries

Sponsored Links

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact STEMCELL Technologies Canada Inc., please visit Company data is provided by S&P Global Market Intelligence. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at